Monte Rosa Therapeutic (NasdaqGS:GLUE) 2025 Conference November 18, 2025 06:30 AM ET Speaker0All right. Good morning. Thank you everyone for joining Jefferies London Healthcare Conference. My name is Clara Dong, one of the biotech analysts here at Jefferies. So sitting next to me, we have the Chief Executive Officer of Monte Rosa Therapeutics, Marcus Warmus.Welcome.Speaker1Yes, thanks. Thanks for the invite. Pleasure to be here.Speaker0So Marcus, before we dive into your individual programs and pipeline, ma ...

Danaher (NYSE:DHR) 2025 Conference November 18, 2025 06:00 AM ET Company ParticipantsRainer Blair - CEOConference Call ParticipantsTycho Peterson - Managing Director and Senior Equity AnalystTycho PetersonOkay. Are we good to go? I think we'll kick it off. Welcome, everybody. I'm Tycho Peterson from the Life Science Tools at Jefferies. I'm pleased to have Rainer Blair with me from Danaher. Maybe, Rainer, to kick it off, we could just start talking a little bit about 2026, coming out of 3Q, and you laid out ...

Zenas BioPharma (NasdaqGS:ZBIO) 2025 Conference November 18, 2025 06:00 AM ET Company ParticipantsLonnie Moulder - CEOConference Call ParticipantsRoger Song - Senior AnalystRoger SongAll right. Welcome, everyone, to Jefferies London Healthcare Conference 2025. My name is Roger Song, one of the senior analysts covering mid-cap biotech in the U.S. It is my pleasure to introduce our next presenting company, Zenas BioPharma CEO, Lonnie Moulder. We will have a hybrid mode, and Lonnie is going to do some presenta ...

Incyte (NasdaqGS:INCY) 2025 Conference November 18, 2025 06:00 AM ET Company ParticipantsPablo Cagnoni - Head of R and DBill Meury - CEOConference Call ParticipantsClara Dunn - Biotech AnalystClara DunnAll right, good morning. Thank you, everyone, for joining Jefferies Healthcare Conference in London. My name is Clara Dunn, one of the biotech analysts here at Jefferies. Sitting next to me, we have the Chief Executive Officer from Incyte, Bill Meury, and the Head of R&D, Pablo Cagnoni. Thank you very much fo ...

Teva Pharmaceutical Industries (NYSE:TEVA) 2025 Conference November 18, 2025 06:00 AM ET Company ParticipantsRichard Francis - CEOConference Call ParticipantsDennis Ding - Biotech and Pharma AnalystDennis DingWelcome to the Jefferies London Healthcare Conference. My name is Dennis Ding, Biotech and Pharma Analyst here at Jefferies, and I have the wonderful pleasure of having Richard Francis here, CEO of Teva. Welcome.Richard FrancisThank you. Thank you very much for having me.Dennis DingObviously, you know, ...

Coherus Oncology (NasdaqGM:CHRS) 2025 Conference November 18, 2025 05:30 AM ET Company ParticipantsDennis Lanfear - CEOOperatorIt is now my pleasure to introduce Dennis Lanfear, CEO of Coherus Oncology.Dennis LanfearThank you. Thank you to the organizers for the opportunity to talk to you about Coherus Oncology, an emerging innovative oncology company based in the Bay Area in Northern California. Let me first apprise you of the company's forward-looking statements and direct you to the requisite SEC filings ...

Align Technology (NasdaqGS:ALGN) 2025 Conference November 18, 2025 05:30 AM ET Company ParticipantsJoe Hogan - President and CEOJohn Morici - CFOConference Call ParticipantsNone - AnalystNoneI'm an analyst on the U.S. Medical Supply and Devices team, and this is a session for Align Technology from the company. We've got Joe Hogan, President and CEO; John Morici, CFO; and we've also got Shirley Stacy here as well. Thank you all for joining us today.Joe HoganOf course. Thanks for having us.I guess just to sta ...

Recursion Pharmaceuticals (NasdaqGS:RXRX) 2025 Conference November 18, 2025 05:30 AM ET Company ParticipantsChris Gibson - Co-Founder and CEONajat Khan - Chief R and D Officer and Chief Commercial OfficerConference Call ParticipantsDennis Ting - Biotech AnalystDennis TingMorning. Welcome to the Jefferies London Healthcare Conference. My name is Dennis Ting, biotech analyst here at Jefferies. I have the wonderful pleasure of having Recursion Pharmaceuticals up here with us. We have Chris Gibson and also Naja ...

Bicycle Therapeutics (NasdaqGS:BCYC) 2025 Conference November 18, 2025 05:30 AM ET Company ParticipantsJennifer Perry - Chief Strategy OfficerAlethia Young - CFOKevin Lee - CEOConference Call ParticipantsClara Dong - Biotech AnalystClara DongAll right, good morning. Thank you, everyone, for joining Jefferies Healthcare Conference in London. My name is Clara Dong, one of the biotech analysts here at Jefferies. For this session, it's my pleasure to welcome the Bicycle Therapeutics team. We have the Chief Exec ...

BioMarin Pharmaceutical (NasdaqGS:BMRN) 2025 Conference November 18, 2025 05:30 AM ET Company ParticipantsGreg Friberg - EVP and Chief Research & Development OfficerAkash Tiwari - Global Head of Biopharmaceutical ResearchBrian Mueller - EVP and CFOAlexander Hardy - President and CEOAkash TiwariAlrighty, I think everyone's just getting in. Day two of our London Healthcare Conference. Great to see everyone. Always really appreciative of the attendance. My name's Akash Tiwari. I'm a pharma and biotech analyst ...